RA
RARE.V
—
TSX Venture
Non-Gold Precious Metals & Minerals
Tactical Resources Corp
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
68,3M CAD
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
333,0 %
Net margin
—
Debt / equity
0,00
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
Tactical Resources Corp is a mining company focused on the exploration and development of non-gold precious metals and minerals.
Business. Tactical Resources Corp (RARE.V) is a mining company engaged in the exploration and development of non-gold precious metals and minerals. The company is headquartered in Canada and is primarily listed on the TSX Venture Exchange. As segment and geographic details are not provided, the firm is described at the industry level within the Basic Materials sector.
Classification92 %
SectorBasic Materials
Business sectorMineral Resources
IndustryNon-Gold Precious Metals & Minerals
ActivityMining
Generated · model-assisted
Sell-side consensus
BUY19 analysts
17 buy2 hold0 sell
Avg 12m price target50,94
Analyst recommendations
19 analysts · consensus BuyBuy17
Hold2
Sell0
12-month price target
50,94
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
19 analysts · indicative
Ownership→
AQR Capital Management, LLC
largest disclosed fund holder
Profitability→
333,0 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to RARE.V. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Tactical Resources Corp (RARE.V) is a mining company engaged in the exploration and development of non-gold precious metals and minerals. The company is headquartered in Canada and is primarily listed on the TSX Venture Exchange. As segment and geographic details are not provided, the firm is described at the industry level within the Basic Materials sector.
Classification92 %
SectorBasic Materials
Business sectorMineral Resources
IndustryNon-Gold Precious Metals & Minerals
ActivityMining
AI synthesis
GENERATEDTactical Resources Corp has a negative equity position of CAD -218,410 and a current ratio of 0.48, indicating significant liquidity constraints. The company's market capitalization is CAD 61,097,511.87, with a market price of CAD 7.29 per share. Despite a positive return on equity of 3.33%, the return on assets is negative at -1.197%, reflecting poor asset utilization.
The company reported a net loss of CAD 727,230 and an operating loss of CAD 713,520 in the latest period. These figures are below the industry median for profitability metrics, suggesting underperformance relative to peers. The negative operating cash flow of CAD -811,690 and free cash flow of CAD -726,570 further highlight the company's cash flow challenges.
Tactical Resources Corp does not disclose segment or geographic revenue breakdowns in the available data, making it difficult to assess revenue concentration or geographic exposure. The absence of segment data limits the ability to evaluate the company's diversification strategy or identify high-growth areas.
The company's outlook for the current fiscal year is constrained by ongoing losses and negative cash flows. With no capital expenditures reported and a lack of long-term debt, the company appears to be in a holding pattern rather than investing in growth. The absence of a clear growth trajectory is compounded by the lack of disclosed revenue history beyond the most recent period.
The risk assessment indicates low liquidity and low dilution risk, with no immediate filing-based flags detected. However, the negative equity position and low current ratio suggest a high liquidity risk. The company's dilution potential is also low, as there are no signs of recent or planned share issuances that could dilute existing shareholders.
No recent filings or transcripts are available in the provided data to assess management commentary or strategic direction. The lack of recent events makes it difficult to gauge the company's response to market conditions or operational challenges.
Key takeaways
- Tactical Resources Corp is a mining company with a negative equity position and significant liquidity constraints.
- The company reported a net loss and negative cash flows in the latest period, indicating poor financial performance.
- The absence of segment and geographic data limits the ability to assess diversification and growth opportunities.
- The company has low liquidity and dilution risk, but its financial position remains precarious.
- No recent events or strategic updates are available to inform the company's future direction.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation FY
Market price
$8,15
Market cap
$61.1M
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
-$218.4k
Net cashⓘ
—
Current ratioⓘ
0.5
Debt / equityⓘ
0.0
ROAⓘ
-1.2%
ROEⓘ
3.3%
Cash conversionⓘ
112.0%
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships16 disclosed relationships · 2 types · extracted from filings & disclosures
Suppliers1
REGENERON PHARMACEUTICALS, INC.REGN.OSupplier90%Source ↗
Subsidiaries15
EX21:0a546fcadf1eEX21:0a546fcadf1eSubsidiarie97%
EX21:1173df31ed24EX21:1173df31ed24Subsidiarie97%
EX21:1fd3f799d852EX21:1fd3f799d852Subsidiarie97%
EX21:2e5f43bfc36bEX21:2e5f43bfc36bSubsidiarie97%
EX21:30cc3da8f58cEX21:30cc3da8f58cSubsidiarie97%
EX21:3ed442bae098EX21:3ed442bae098Subsidiarie97%
EX21:429346a47211EX21:429346a47211Subsidiarie97%
EX21:7d4333fc4d15EX21:7d4333fc4d15Subsidiarie97%
EX21:8908690bf842EX21:8908690bf842Subsidiarie97%
EX21:9a9682d0afc7EX21:9a9682d0afc7Subsidiarie97%
EX21:a3222889c7f0EX21:a3222889c7f0Subsidiarie97%
EX21:a5e9f3e83503EX21:a5e9f3e83503Subsidiarie97%
EX21:a9a4be89f9b7EX21:a9a4be89f9b7Subsidiarie97%
EX21:b7f3e3580accEX21:b7f3e3580accSubsidiarie97%
EX21:c910489eecc9EX21:c910489eecc9Subsidiarie97%
Supply chain
Vendors → RARE ↔ Partners → Customers · click any node to drill
1 mention in 10-K0 from corporate websites0 from news dispatches
Updated 2026-06-24Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-4,63
Predicted surprise
-0,00
Beat probability
45 %
Analysts
19
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-07-10 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Corporate eventM&A horizon
M&A probabilityconf 3 %
Probability
3 %
Base rate
3 %
Band
—
180-day horizon · target 2027-01-19 · 1,0× base rate
No acquirer candidates identified by the signal model.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$25,00
Mean$50,94
Median$47,50
High$96,00
Spot$8,15
+525.1 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskLow
Filing-based flags
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
ROE333,0 %Best in class
D/E0,00Above median
Cash Conv1,12Above median
Corporate actions / M&A
M&A probabilityconf —
Probability
3 %
Base rate
3 %
Band
Low
180-day horizon · target 2027-01-19 · 1,0× base rate
No acquirer candidates identified by the signal model.
Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 618 143 sh15 grants15 insiders
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- Director · Stock Option (Right to Buy) → Common StockAcquired 14 058 @ $25,80grant · 2026-05-14
- SVP, Chief Accounting Officer · Stock Option (Right to Buy) → Common StockAcquired 7 348 @ $24,61grant · 2026-04-22
- EVP and Chief Legal Officer · Stock Option (Right to Buy) → Common StockAcquired 49 960 @ $24,52grant · 2026-04-16
- Director, President & CEO · Stock Option (Right to Buy) → Common StockAcquired 132 693 @ $24,52grant · 2026-04-16
- See Remarks · Stock Option (Right to Buy) → Common StockAcquired 79 936 @ $24,52grant · 2026-04-16
- See Remarks · Stock Option (Right to Buy) → Common StockAcquired 79 936 @ $24,52grant · 2026-04-16
- EVP & Chief Commercial Officer · Stock Option (Right to Buy) → Common StockAcquired 49 960 @ $24,52grant · 2026-04-16
- EVP and Chief Medical Officer · Stock Option (Right to Buy) → Common StockAcquired 59 952 @ $24,52grant · 2026-04-16
- Chief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 59 952 @ $24,52grant · 2026-04-16
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- Tactical Resources Corp Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,04 %$96M
- Investment Managers · as of 2026-03-310,01 %$55M
- Investment Managers · as of 2024-06-300,01 %$230M
- Investment Managers · as of 2024-12-310,00 %$16M
- Investment Managers · as of 2026-03-310,00 %$105M
- Investment Managers · as of 2025-12-310,00 %$236M
- Investment Managers · as of 2026-03-310,00 %$17M
- Investment Managers · as of 2026-03-310,00 %$39M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$31M
- Institutional Investor · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$11M
- Institutional Investor · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$7M
- Funds · as of 2026-03-310,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
Net selling0 buys · 13 sellsnet -$2,6M15 insiders · last 365d
- Chief Financial Officer · Common StockSold 4 698 @ $33,13$156K · 2026-07-01
- Director · Common StockSold 2 000 @ $25,05$50K · 2026-06-15
- EVP and Chief Legal Officer · Common StockSold 1 899 @ $24,62$47K · 2026-06-15
- Chief Financial Officer · Common StockSold 4 653 @ $23,77$111K · 2026-06-01
- Director · Common StockSold 5 740 @ $25,12$144K · 2026-05-18
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- Director · Common StockOther 7 751 · 2026-05-14
- EVP and Chief Medical Officer · Common StockSold 344 @ $24,96$9K · 2026-05-05
- Chief Financial Officer · Common StockSold 4 683 @ $24,90$117K · 2026-05-01
- SVP, Chief Accounting Officer · Common StockOther 20 241 · 2026-04-22
- See Remarks · Common StockOther 23 116 · 2026-04-16
- Director, President & CEO · Common StockOther 76 745 · 2026-04-16
- See Remarks · Common StockOther 23 116 · 2026-04-16
- EVP and Chief Legal Officer · Common StockOther 28 895 · 2026-04-16
- EVP & Chief Commercial Officer · Common StockOther 28 895 · 2026-04-16
- EVP and Chief Medical Officer · Common StockOther 34 674 · 2026-04-16
- Chief Financial Officer · Common StockOther 34 674 · 2026-04-16
- Chief Financial Officer · Common StockSold 4 683 @ $20,97$98K · 2026-04-01
- EVP and Chief Legal Officer · Common StockSold 3 508 @ $22,67$80K · 2026-03-10
- EVP and Chief Legal Officer · Common StockSold 6 018 @ $21,40$129K · 2026-03-06
Short positioning
13.4Mshares short-17.2% vs prior
6.94days to cover
28.4%short of daily vol
1fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
RARE.VCanonical
TSX Venture · CAD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskLow
No immediate filing-based liquidity or dilution flags were detected.
Relationship graph
This companySectorSuppliersSubsidiaries
Evidence & claims
From filings & derived data- Current ratio (FY 2025-12-31): 2.48xDerived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 29.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1.9%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -131.4%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 20.2%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -12.6%Derived (calculated)
- Net margin (FY 2025-12-31): -85.4%Derived (calculated)
- Return on equity (FY 2025-12-31): 718.8%Derived (calculated)
- Return on assets (FY 2025-12-31): -37.5%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -20.06xDerived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 0.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -14.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -1.1%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 142.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 7.4%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 7.3%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 7.3%Derived (calculated)
- Current assets (annual): USD 951MSEC XBRL filing
- Revenue (annual): USD 673MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -6SEC XBRL filing
- Operating cash flow (annual): USD -466MSEC XBRL filing
- Shares outstanding (annual): 96.6MSEC XBRL filing
- Total assets (annual): USD 1.53BSEC XBRL filing
- Current liabilities (annual): USD 384MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-08-04 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
2026-08-04EVENTUpcomingQ2 2026 earnings (expected) estimated date
2026-07-01INSIDERHorn Howard sold 4.7k sh — Chief Financial Officer ~$156k
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: insider_flow_signal (90d)
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
2026-06-24 03:12 UTCHOLDERInstitutional holding changed
2026-06-24 03:12 UTCHOLDER1 institutional position change flagged (1 major)
2026-06-21 02:57 UTCHOLDERInstitutional holding changed
2026-06-21 02:57 UTCHOLDER1 institutional position change flagged (1 major)
2026-06-15 00:00 UTCINSIDER3 insider transactions — 2026-06 · net sell $207k
2026-06-15INSIDERSanders Corazon (Corsee) D. sold 2.0k sh — Director ~$50k
2026-06-15INSIDERParschauer Karah Herdman sold 1.9k sh — EVP and Chief Legal Officer ~$47k
2026-06-01INSIDERHorn Howard sold 4.7k sh — Chief Financial Officer ~$111k
2026-05-18 00:00 UTCINSIDER17 insider transactions — 2026-05 · net sell $269k 7 derivative
2026-05-18INSIDERSULIMAN SHEHNAAZ sold 5.7k sh — Director ~$144k
2026-05-14INSIDERSULIMAN SHEHNAAZ transacted 7.8k sh — Director
2026-05-14INSIDERFust Matthew K transacted 7.8k sh — Director
2026-05-14INSIDERRay Amrit transacted 7.8k sh — Director
2026-05-14INSIDERSanders Corazon (Corsee) D. transacted 7.8k sh — Director
2026-05-14INSIDERNARACHI MICHAEL transacted 7.8k sh — Director
2026-05-14INSIDERWELCH DANIEL G transacted 7.8k sh — Director
2026-05-14INSIDERDunsire Deborah transacted 7.8k sh — Director
2026-05-14INSIDERRay Amrit acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERSULIMAN SHEHNAAZ acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERFust Matthew K acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERNARACHI MICHAEL acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERWELCH DANIEL G acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERSanders Corazon (Corsee) D. acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-14INSIDERDunsire Deborah acquired 14.1k sh Stock Option (Right to Buy) — Director
2026-05-05INSIDERCrombez Eric sold 344 sh — EVP and Chief Medical Officer ~$9k
2026-05-01INSIDERHorn Howard sold 4.7k sh — Chief Financial Officer ~$117k
2026-04-22 00:00 UTCINSIDER17 insider transactions — 2026-04 8 derivative
2026-04-22INSIDERHuizenga Theodore Alan transacted 20.2k sh — SVP, Chief Accounting Officer
2026-04-22INSIDERHuizenga Theodore Alan acquired 7.3k sh Stock Option (Right to Buy) — SVP, Chief Accounting Officer
2026-04-16INSIDERPinion John Richard transacted 23.1k sh — See Remarks
2026-04-16INSIDERKAKKIS EMIL D transacted 76.7k sh — Director, President & CEO
2026-04-16INSIDERHuang Dennis Karl transacted 23.1k sh — See Remarks
Showing the 40 most recent of 64 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage